Direktorat Registrasi ObatValid

TANAXEL

Claim this product
BPOM Number
DKL1943901243A1
Approved
21 November 2024
Expiry
2 November 2024
Form
INJEKSI; 6 MG

About This Registration

TANAXEL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1943901243A1. Its current registration status is Valid, with the licence valid until 2 November 2024. The product is registered to CKD OTTO PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in November 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 5 ML
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

PACLITAXEL

Market Intelligence

Owner Portfolio
CKD OTTO PHARMACEUTICALS - INDONESIA holds 49 BPOM registrations
Manufacturer Scale
CKD OTTO PHARMACEUTICALS - INDONESIA produces 49 registered products
Registration Age
Registered for 6 years, 10 months
Expiry Status
Expired 691 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from CKD OTTO PHARMACEUTICALS - INDONESIA

BELLVESTRANT

-DKI2699801143A1
Valid
Approved: Aug 16, 2026INJEKSI
View product →

BEVABELL

-DKI2570200149A1
Valid
Approved: May 9, 2026LARUTAN KONSENTRAT UNTUK INFUS
View product →

BORTEZOMIB

-GKL2543902044B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

TEZOBELL

-DKL2543901944B1
Valid
Approved: Dec 28, 2025SERBUK INJEKSI LIOFILISASI
View product →

MYREPT

-DKI2584401309A1
Valid
Approved: Aug 31, 2025KAPLET SALUT SELAPUT
View product →

Products in the same class

CETIGRA

-DTL1931116801A1
Valid
Approved: Mar 18, 2026KAPSUL
GRAHA FARMA - INDONESIA
View product →

CEFADROXIL MONOHYDRATE

-GKL2025906901A1
Valid
Approved: Dec 21, 2025KAPSUL
TRIMAN
View product →

MORVALE

-DKL1441001129A1
Valid
Approved: Nov 23, 2025KRIM
IMMORTAL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

METRONIDAZOLE

-GKL2535315849A1
Valid
Approved: Aug 12, 2025INFUS
GRACIA PHARMINDO
View product →

ORASIC

-DKL9618813543A1
Valid
Approved: Aug 7, 2025INJEKSI
OTTO PHARMACEUTICAL INDUSTRIES - INDONESIA
View product →
1